Rafferty Asset Management
INBX icon

Rafferty Asset Management’s Inhibrx INBX Stock Holding History

Rafferty Asset Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Sell
11,148
-4,613
-29% -$462K ﹤0.01% 778
2026
Q1 		$1.06M Buy
15,761
+7,179
+84% +$533K ﹤0.01% 750
2025
Q4 		$678K Buy
+8,582
New +$585K ﹤0.01% 860

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Rafferty Asset Management's INBX Position: Q2 2026 in Review

Rafferty Asset Management reduced its Inhibrx (INBX) stake by 29% in Q2 2026, selling an estimated $462K and leaving 11,148 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #778.

Rafferty Asset Management first reported a position in INBX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.06M in Q1 2026. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Rafferty Asset Management held 11,148 shares of Inhibrx worth $1.06M as of Q2 2026.
  • Rafferty Asset Management sold 4,613 Inhibrx shares in Q2 2026, an estimated $462K.
  • Inhibrx made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #778 holding.
  • Rafferty Asset Management first reported a position in Inhibrx in Q4 2025 and has held it in 3 quarters since.
  • Rafferty Asset Management's Inhibrx position peaked at $1.06M in Q1 2026.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.